Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study

By Choi Peter   Farouk Mourad   Manamley Nick   Addison Janet  

Advances in Therapy, Vol. 30, Iss. 11, 2013-11 ,pp. : 1007-1017

Springer Publishing Company

Access to resources Recommend Favorite

Dosing patterns, drug costs, and hematologic outcome in anemic patients with chronic kidney disease switching from darbepoetin alfa to epoetin alfa

By Hymes Jeffrey   Bickimer Tammy   Jackson James H.   Bookhart Brahim K.   Mody Samir H.   Tak Piech Catherine  

Current Medical Research and Opinion, Vol. 23, Iss. 8, 2007-08 ,pp. : 1931-1937

Informa Healthcare

Access to resources Recommend Favorite

A randomised, cross-over study comparing injection site pain with subcutaneous epoetin beta and subcutaneous darbepoetin alfa in patients with chronic kidney disease

By Roger Simon D.   Suranyi Michael G.   Walker Rowan G.    

Current Medical Research and Opinion, Vol. 24, Iss. 8, 2008-08 ,pp. : 2181-2187

Informa Healthcare

Access to resources Recommend Favorite

Switching from Epoetin Alpha to Darbepoetin Alpha in Japanese Hemodialysis Patients: Dose Conversion Ratio

By  

Nephron Clin Pract, Vol. 111, Iss. 2, 2008-12 ,pp. : c81-c86

Karger

Access to resources Recommend Favorite

The cost-effectiveness of weekly epoetin alfa relative to weekly darbepoetin alfa in patients with chemotherapy-induced anemia

By Ben-Hamadi R.   Duh M. S.   Aggarwal J.   Henckler A.   Mckenzie R. S.   Tak Piech C.  

Current Medical Research and Opinion, Vol. 21, Iss. 10, 2005-10 ,pp. : 1677-1682

Informa Healthcare

Access to resources Recommend Favorite